Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:44:49.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T14:50:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, signaling that the study page is inaccessible; a Home link appears as part of the error page's navigation.
    Difference
    0.5%
    Check dated 2026-09-26T16:40:13.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study details with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-19T19:05:23.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added NIH grant/contract attribution for 2016 and updated the documentation revision to v3.6.6, reflecting a minor metadata update.
    Difference
    0.1%
    Check dated 2026-08-29T18:28:57.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5. This is a metadata version refresh that does not reflect changes to substantive content.
    Difference
    0.0%
    Check dated 2026-08-08T10:21:33.000Z thumbnail image

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.